Report Detail

Pharma & Healthcare Global Artificial Intelligence (AI) in Pharmaceutical Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • RnM4389903
  • |
  • 05 March, 2022
  • |
  • Global
  • |
  • 101 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

The Artificial Intelligence (AI) in Pharmaceutical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Artificial Intelligence (AI) in Pharmaceutical market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Pharmaceutical Company accounting for % of the Artificial Intelligence (AI) in Pharmaceutical global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hardware segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Artificial Intelligence (AI) in Pharmaceutical include AstraZeneca LLC, Atomwise Inc, Bayer AG, Cloud Pharmaceuticals Inc, and GNS Healthcare, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Artificial Intelligence (AI) in Pharmaceutical market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Hardware
Software

Market segment by Application, can be divided into
Pharmaceutical Company
Institute of Biology
Others

Market segment by players, this report covers
AstraZeneca LLC
Atomwise Inc
Bayer AG
Cloud Pharmaceuticals Inc
GNS Healthcare
IBM Watson
Merck & Co.
Microsoft Corporation
Novartis AG
NVIDIA Corporation
Pfizer Inc.
Recursion Pharmaceuticals Inc.
XtalPi Inc

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Artificial Intelligence (AI) in Pharmaceutical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Artificial Intelligence (AI) in Pharmaceutical, with revenue, gross margin and global market share of Artificial Intelligence (AI) in Pharmaceutical from 2019 to 2022.
Chapter 3, the Artificial Intelligence (AI) in Pharmaceutical competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Artificial Intelligence (AI) in Pharmaceutical market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Artificial Intelligence (AI) in Pharmaceutical research findings and conclusion, appendix and data source.


1 Market Overview

  • 1.1 Product Overview and Scope of Artificial Intelligence (AI) in Pharmaceutical
  • 1.2 Classification of Artificial Intelligence (AI) in Pharmaceutical by Type
    • 1.2.1 Overview: Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Type: 2017 Versus 2021 Versus 2028
    • 1.2.2 Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Type in 2021
    • 1.2.3 Hardware
    • 1.2.4 Software
  • 1.3 Global Artificial Intelligence (AI) in Pharmaceutical Market by Application
    • 1.3.1 Overview: Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Application: 2017 Versus 2021 Versus 2028
    • 1.3.2 Pharmaceutical Company
    • 1.3.3 Institute of Biology
    • 1.3.4 Others
  • 1.4 Global Artificial Intelligence (AI) in Pharmaceutical Market Size & Forecast
  • 1.5 Global Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast by Region
    • 1.5.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Region: 2017 VS 2021 VS 2028
    • 1.5.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Region, (2017-2022)
    • 1.5.3 North America Artificial Intelligence (AI) in Pharmaceutical Market Size and Prospect (2017-2028)
    • 1.5.4 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size and Prospect (2017-2028)
    • 1.5.5 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size and Prospect (2017-2028)
    • 1.5.6 South America Artificial Intelligence (AI) in Pharmaceutical Market Size and Prospect (2017-2028)
    • 1.5.7 Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Market Size and Prospect (2017-2028)
  • 1.6 Market Drivers, Restraints and Trends
    • 1.6.1 Artificial Intelligence (AI) in Pharmaceutical Market Drivers
    • 1.6.2 Artificial Intelligence (AI) in Pharmaceutical Market Restraints
    • 1.6.3 Artificial Intelligence (AI) in Pharmaceutical Trends Analysis

2 Company Profiles

  • 2.1 AstraZeneca LLC
    • 2.1.1 AstraZeneca LLC Details
    • 2.1.2 AstraZeneca LLC Major Business
    • 2.1.3 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Product and Solutions
    • 2.1.4 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.1.5 AstraZeneca LLC Recent Developments and Future Plans
  • 2.2 Atomwise Inc
    • 2.2.1 Atomwise Inc Details
    • 2.2.2 Atomwise Inc Major Business
    • 2.2.3 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Product and Solutions
    • 2.2.4 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.2.5 Atomwise Inc Recent Developments and Future Plans
  • 2.3 Bayer AG
    • 2.3.1 Bayer AG Details
    • 2.3.2 Bayer AG Major Business
    • 2.3.3 Bayer AG Artificial Intelligence (AI) in Pharmaceutical Product and Solutions
    • 2.3.4 Bayer AG Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.3.5 Bayer AG Recent Developments and Future Plans
  • 2.4 Cloud Pharmaceuticals Inc
    • 2.4.1 Cloud Pharmaceuticals Inc Details
    • 2.4.2 Cloud Pharmaceuticals Inc Major Business
    • 2.4.3 Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Product and Solutions
    • 2.4.4 Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.4.5 Cloud Pharmaceuticals Inc Recent Developments and Future Plans
  • 2.5 GNS Healthcare
    • 2.5.1 GNS Healthcare Details
    • 2.5.2 GNS Healthcare Major Business
    • 2.5.3 GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Product and Solutions
    • 2.5.4 GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.5.5 GNS Healthcare Recent Developments and Future Plans
  • 2.6 IBM Watson
    • 2.6.1 IBM Watson Details
    • 2.6.2 IBM Watson Major Business
    • 2.6.3 IBM Watson Artificial Intelligence (AI) in Pharmaceutical Product and Solutions
    • 2.6.4 IBM Watson Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.6.5 IBM Watson Recent Developments and Future Plans
  • 2.7 Merck & Co.
    • 2.7.1 Merck & Co. Details
    • 2.7.2 Merck & Co. Major Business
    • 2.7.3 Merck & Co. Artificial Intelligence (AI) in Pharmaceutical Product and Solutions
    • 2.7.4 Merck & Co. Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.7.5 Merck & Co. Recent Developments and Future Plans
  • 2.8 Microsoft Corporation
    • 2.8.1 Microsoft Corporation Details
    • 2.8.2 Microsoft Corporation Major Business
    • 2.8.3 Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Product and Solutions
    • 2.8.4 Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.8.5 Microsoft Corporation Recent Developments and Future Plans
  • 2.9 Novartis AG
    • 2.9.1 Novartis AG Details
    • 2.9.2 Novartis AG Major Business
    • 2.9.3 Novartis AG Artificial Intelligence (AI) in Pharmaceutical Product and Solutions
    • 2.9.4 Novartis AG Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.9.5 Novartis AG Recent Developments and Future Plans
  • 2.10 NVIDIA Corporation
    • 2.10.1 NVIDIA Corporation Details
    • 2.10.2 NVIDIA Corporation Major Business
    • 2.10.3 NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Product and Solutions
    • 2.10.4 NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.10.5 NVIDIA Corporation Recent Developments and Future Plans
  • 2.11 Pfizer Inc.
    • 2.11.1 Pfizer Inc. Details
    • 2.11.2 Pfizer Inc. Major Business
    • 2.11.3 Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Product and Solutions
    • 2.11.4 Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.11.5 Pfizer Inc. Recent Developments and Future Plans
  • 2.12 Recursion Pharmaceuticals Inc.
    • 2.12.1 Recursion Pharmaceuticals Inc. Details
    • 2.12.2 Recursion Pharmaceuticals Inc. Major Business
    • 2.12.3 Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Product and Solutions
    • 2.12.4 Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.12.5 Recursion Pharmaceuticals Inc. Recent Developments and Future Plans
  • 2.13 XtalPi Inc
    • 2.13.1 XtalPi Inc Details
    • 2.13.2 XtalPi Inc Major Business
    • 2.13.3 XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Product and Solutions
    • 2.13.4 XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.13.5 XtalPi Inc Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Artificial Intelligence (AI) in Pharmaceutical Revenue and Share by Players (2019, 2020, 2021, and 2022)
  • 3.2 Market Concentration Rate
    • 3.2.1 Top 3 Artificial Intelligence (AI) in Pharmaceutical Players Market Share in 2021
    • 3.2.2 Top 10 Artificial Intelligence (AI) in Pharmaceutical Players Market Share in 2021
    • 3.2.3 Market Competition Trend
  • 3.3 Artificial Intelligence (AI) in Pharmaceutical Players Head Office, Products and Services Provided
  • 3.4 Artificial Intelligence (AI) in Pharmaceutical Mergers & Acquisitions
  • 3.5 Artificial Intelligence (AI) in Pharmaceutical New Entrants and Expansion Plans

4 Market Size Segment by Type

  • 4.1 Global Artificial Intelligence (AI) in Pharmaceutical Revenue and Market Share by Type (2017-2022)
  • 4.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

  • 5.1 Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Application (2017-2022)
  • 5.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

  • 6.1 North America Artificial Intelligence (AI) in Pharmaceutical Revenue by Type (2017-2028)
  • 6.2 North America Artificial Intelligence (AI) in Pharmaceutical Revenue by Application (2017-2028)
  • 6.3 North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country
    • 6.3.1 North America Artificial Intelligence (AI) in Pharmaceutical Revenue by Country (2017-2028)
    • 6.3.2 United States Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)
    • 6.3.3 Canada Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)
    • 6.3.4 Mexico Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

  • 7.1 Europe Artificial Intelligence (AI) in Pharmaceutical Revenue by Type (2017-2028)
  • 7.2 Europe Artificial Intelligence (AI) in Pharmaceutical Revenue by Application (2017-2028)
  • 7.3 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Country
    • 7.3.1 Europe Artificial Intelligence (AI) in Pharmaceutical Revenue by Country (2017-2028)
    • 7.3.2 Germany Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)
    • 7.3.3 France Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)
    • 7.3.4 United Kingdom Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)
    • 7.3.5 Russia Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)
    • 7.3.6 Italy Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

  • 8.1 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Revenue by Type (2017-2028)
  • 8.2 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Revenue by Application (2017-2028)
  • 8.3 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Region
    • 8.3.1 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Revenue by Region (2017-2028)
    • 8.3.2 China Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)
    • 8.3.3 Japan Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)
    • 8.3.4 South Korea Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)
    • 8.3.5 India Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)
    • 8.3.6 Southeast Asia Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)
    • 8.3.7 Australia Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

  • 9.1 South America Artificial Intelligence (AI) in Pharmaceutical Revenue by Type (2017-2028)
  • 9.2 South America Artificial Intelligence (AI) in Pharmaceutical Revenue by Application (2017-2028)
  • 9.3 South America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country
    • 9.3.1 South America Artificial Intelligence (AI) in Pharmaceutical Revenue by Country (2017-2028)
    • 9.3.2 Brazil Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)
    • 9.3.3 Argentina Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

  • 10.1 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Revenue by Type (2017-2028)
  • 10.2 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Revenue by Application (2017-2028)
  • 10.3 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Country
    • 10.3.1 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Revenue by Country (2017-2028)
    • 10.3.2 Turkey Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)
    • 10.3.3 Saudi Arabia Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)
    • 10.3.4 UAE Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

    12 Appendix

    • 12.1 Methodology
    • 12.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Artificial Intelligence (AI) in Pharmaceutical. Industry analysis & Market Report on Artificial Intelligence (AI) in Pharmaceutical is a syndicated market report, published as Global Artificial Intelligence (AI) in Pharmaceutical Market 2022 by Company, Regions, Type and Application, Forecast to 2028. It is complete Research Study and Industry Analysis of Artificial Intelligence (AI) in Pharmaceutical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $6,960.00
    2,794.44
    5,588.88
    3,253.80
    6,507.60
    539,852.40
    1,079,704.80
    290,058.00
    580,116.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report